The Verdict: Limited and preliminary
doi:10.1016/s0899-9007(02)00807-9
Dear Marci, My doctor and I have been discussing some of the new GLP-1 weight loss medications
For example, prescribing data for one oral GLP-1 tablet reported that among patients who had gastrointestinal side effects, 60% were mild, 36% were moderate and 4% were severe
Injectable GLP-1s are delivered directly into the bloodstream via the subcutaneous tissue, allowing for nearly 100% bioavailability
Modulacin de Parmetros Metablicos: Adems de la reduccin del peso, se observan mejoras en marcadores metablicos, tales como la sensibilidad a la insulina y la reduccin de la inflamacin sistmica, lo que potencialmente disminuye el riesgo de desarrollar complicaciones asociadas a la obesidad